TECTONIC THERAPEUTIC, INC. (TECX) Free cash flow 2017–2025
TECTONIC THERAPEUTIC, INC. (TECX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$60.3MFY2025 · since FY2017: -$16.8M → -$60.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.3M | -1.8% |
| FY2024 | -$59.2M | -44.6% |
| FY2023 | -$41.0M | +58.0% |
| FY2022 | -$97.5M | +3.0% |
| FY2021 | -$100.5M | -0.5% |
| FY2020 | -$100.0M | -44.4% |
| FY2019 | -$69.3M | -75.4% |
| FY2018 | -$39.5M | -135.5% |
| FY2017 | -$16.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TECX financial trends
TECX RevenueTECX Net incomeTECX Net marginTECX Gross profitTECX Gross marginTECX Operating incomeTECX Operating marginTECX Operating cash flowTECX Capital expendituresTECX Return on equityTECX Stock buybacksTECX Dividends paidTECX Total assetsTECX Total liabilitiesTECX Shareholders’ equityTECX overview →